Biopharm, a leading pharmaceutical company in Algeria, has been awarded the prestigious title of 'Excellence in Generic Medicine Development, Algeria, 2024' by Global Brands Magazine (GBM) at the renowned Global Brand Awards. This distinguished recognition underscores Biopharm's exceptional dedication to pioneering innovation and advancing public health through high-quality generic medicines.
The Global Brand Awards celebrate the highest achievements across industries worldwide. Biopharm received this award for its dedication to healthcare innovation and excellence in developing generic medicines.
Jay Reddy, CEO of Global Brands Magazine, commented, "We are pleased to honour Biopharm with the Excellence in Generic Medicine Development award in Algeria. This accolade is a testament to their unwavering commitment to innovation, quality, and accessibility in the pharmaceutical industry. It's an honour to celebrate their dedication to improving lives through ground breaking solutions."
"By placing the patient at the heart of our research and activities, Biopharm continues to develop accessible and effective therapeutic solutions, while adopting sustainable and responsible practices. Thereby, this award illustrates perfectly our ability to combine operational excellence, scientific commitment, and the desire to improve the health of patients. Developing quality medicines accessible to as many people as possible is at the core of our mission," said Abdelhalim BENMERAD,CEO, Biopharm.
Comments powered by CComment